HIK · HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY · Investor Relations
Market Cap
3.41B GBP
Shares
206.97M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-20 00:00 UTC | Hikma R&D Investor Spotlight Series: Group R&D and Respiratory, Nasal, Semi-Solids and Liquids (14:00 BST) | Event |
| 2026-10-20 00:00 UTC | Hikma R&D Spotlight Series | Group R&D and Respiratory, Nasal, Semi-Solids and Liquids (Virtual) | Event |
| 2026-11-05 00:00 UTC | November Trading Update | Event |
| 2026-11-17 00:00 UTC | J.P. Morgan UK Leaders Conference, London | Conference |
| 2026-11-18 00:00 UTC | Jefferies Global Healthcare Conference, London | Conference |
| 2026-11-24 00:00 UTC | Hikma R&D Investor Spotlight Series: Solid Orals (14:00 BST) | Event |
| 2026-11-24 00:00 UTC | Hikma R&D Spotlight Series | Solid Orals (Virtual) | Event |
| 2026-12-16 00:00 UTC | Hikma R&D Investor Spotlight Series: Injectables (14:00 BST) | Event |
| 2026-12-16 00:00 UTC | Hikma R&D Spotlight Series | Injectables (Virtual) | Event |
Past events
Source: http://www.hikma.com/investors